Tacrolimus (FK506) proves superior to OKT3 for treating episodes of persistent rejection following intrathoracic transplantation

Transplant Proc. 1997 Feb-Mar;29(1-2):605-6. doi: 10.1016/s0041-1345(96)00321-1.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Antilymphocyte Serum / therapeutic use
  • Drug Therapy, Combination
  • Graft Rejection / drug therapy*
  • Heart Transplantation / immunology*
  • Heart Transplantation / methods
  • Heart-Lung Transplantation / immunology*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Lung Transplantation / immunology*
  • Methotrexate / therapeutic use
  • Methylprednisolone / therapeutic use
  • Muromonab-CD3 / therapeutic use*
  • Tacrolimus / therapeutic use*

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Muromonab-CD3
  • Tacrolimus
  • Methylprednisolone
  • Methotrexate